The Drug Overdose Epidemic: Harm Reduction and the Role of the Pharmacist

Online home study activity

Start date:  August 19, 2024

End date:   August 31, 2025

Register online now

Target Audience

Pharmacists in all practice settings and other clinical health care providers

Why you should attend

Pharmacists are among the most accessible healthcare providers in the United States and are uniquely positioned to provide harm reduction services. Pharmacists are considered underutilized health providers. This training provides an overview of the role of the pharmacist in harm reduction as well as practices for providing harm reduction services. This course will identify barriers to implementing these services and highlight strategies for pharmacists to implement these services.

On this page:

Learning Objectives

  1. Describe harm reduction strategies for the pharmacist such as naloxone, syringe access and disposal, and buprenorphine and the NY Public Health Laws that support them.
  2. Identify barriers that limit access to harm reduction interventions and strategies to create a welcoming environment for people who use drugs (PWUD).
  3. Identify emerging drug trends, changes in buprenorphine regulations and the role of pharmacists to address them.
Back to top of page

Program Schedule

This activity contains a pre-test, educational material, educational video, a post-test, and a program evaluation.  Successful achievement of this activity requires achieving a score of 70% or higher on the post-test.

Back to top of page

Presenters

Photo of speaker.
Photo of speaker.

Karl Williams, JD, MBA, MS, BS Pharm

Professor of Pharmacy Ethics and Law

St. John Fisher University, Wegmans School of Pharmacy

  

  

Christopher Woodring, PharmD

Director, Pharmacy Operations

Trillium Health

Back to top of page

Cost and Support

There is no fee for this program and there is no commercial support associated with this educational activity.  This program is supported by the Overdose Data to Action grant from the New York State Department of Health.

Disclosure Declaration

ACPE is committed to ensuring that accredited continuing education (1) presents learners with only accurate, balanced, and scientifically justified recommendations, and (2) protects learners from promotion, marketing, and commercial bias. The individuals involved with the planning and presentation of this activity have the following financial relationships to disclose:

Faculty Disclosures:

Karl Williams, JD, MBA, MS, BS Pharm has nothing to disclose

Christopher Woodring, PharmD has nothing to disclose

 

Planning Committee Disclosures:

Lisa Skill MS, MCHES has nothing to disclose

Clara DeSanctis, MPH has nothing to disclose

Piper Coalson, GCPH has nothing to disclose

Back to top of page

Accreditation Information

ACPE.

The University at Buffalo School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program has been accredited as a knowledge-based activity. Credit will be uploaded to the CPE Monitor to those who complete all components of this activity.  No partial credit is available.

ACPE # 0044-0000-24-022-H08-P, 1.5 contact hours, 0.15 CEU

Questions?

Please email pharmacyce@buffalo.edu  

Back to top of page